Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Fluconazole in AIDS-Associated Cryptococcal Meningitis
NCT00885703Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2010
- Primary completion
- Jan 2017
- Modality
- Orthosteric Ligands
- Countries
- 8
01
Overview
A Phase 2 trial of fluconazole in cryptococcal meningitis, sponsored by National Institute of Allergy and Infectious Diseases. Started Apr 2010; status: completed.
02
Drugs
fluconazole
03
Conditions
cryptococcal meningitis
Beyond the preview
Go deeper on NCT00885703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00885703.